Washington, D.C. ( February 19, 2019) -- State and local governments are lining up to sue the makers of Oxycontin and other addictive drugs. And there’s a side benefit to this. These cases not only address the opioid crisis, but they also advance an important point in deception law. They make it clear that large institutions — such as hospitals — as well as individual consumers should be protected against misleading marketing efforts....